Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ−/− mice
Open Access
- 13 June 2012
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 26 (11), 2432-2435
- https://doi.org/10.1038/leu.2012.154
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient miceJCI Insight, 2011
- Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fractionBlood, 2010
- Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemiaBlood, 2009
- A robust xenotransplantation model for acute myeloid leukemiaLeukemia, 2009
- PML–RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitorsLeukemia, 2009
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal regionNature Biotechnology, 2007
- AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AMLBlood, 2006
- Acute promyelocytic leukemia: where does it stem from?Leukemia, 2004
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997